Riskpilot← Back to searchSign inGet full accessMYSEN PRESTASJON OG HELSE AS
ASActiveOrg 922077274Pennestrøket 11, 1850 MysenOther education n.e.c. · NACE 8559Est. 20196 employees
Revenue 2025
NOK 6,7M
0% vs 2024
EBITDA margin
6.8%
-47% vs 2024
Equity ratio
76.7%
Financial strength
Net profit 2025
NOK 101K
-76% vs 2024
| Revenue | NOK 6,7M | +0% |
| EBITDA | NOK 454K | -47% |
| Net profit | NOK 101K | -76% |
| Total assets | NOK 2,6M | +2% |
| Equity | NOK 2M | +5% |
| Employees | 6 | — |
Legal name
MYSEN PRESTASJON OG HELSE AS
Org number
922077274
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
17. januar 2019
Share capital
NOK 200 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Helse- og treningsveiledning, testing, kvantifisering av helsedata og alt som står i naturlig forbindelse med dette.
Address
Pennestrøket 11, 1850 Mysen
Phone
+4741662286
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 546 | 4 058 | 5 357 | 6 718 | 6 686 |
| Staff expenses | −1 678 | −1 996 | −1 704 | −2 112 | −2 193 |
| EBITDA | 478 | 432 | 667 | 854 | 454 |
| Depreciation & amort. | −168 | −209 | −283 | −301 | −323 |
| EBIT | 310 | 223 | 384 | 553 | 130 |
| Net financials | 0 | 0 | −15 | −1 | −0 |
| Profit before tax | 310 | 223 | 369 | 552 | 130 |
| Tax | 69 | 49 | 81 | 122 | 29 |
| Net profit | 241 | 174 | 288 | 430 | 101 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 693 | 2 369 | 2 743 | 2 559 | 2 612 |
| Equity | 1 670 | 1 184 | 1 472 | 1 902 | 2 004 |
| Long-term debt | 93 | 100 | 112 | 111 | 98 |
| Short-term debt | 930 | 1 084 | 1 159 | 546 | 510 |
| Total debt | 1 023 | 1 185 | 1 271 | 657 | 609 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20212025
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20212025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20212025
Asset turnover
2.56×
This company
1.12×
Market median
+129% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SC Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MYSEN PRESTASJON OG HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigurd Cornelius Diepens | Chief Executive Officer | 0 companies |
| Jørgen Undrum | Chairman | 0 companies |
| Marielle Moan Røssås | Board of Directors | 0 companies |
| Charlotte Greger Ree Diepens | Board of Directors | 0 companies |